Skip to main content
. Author manuscript; available in PMC: 2021 Apr 24.
Published in final edited form as: Oral Oncol. 2020 Aug 29;111:104981. doi: 10.1016/j.oraloncology.2020.104981

Figure 1.

Figure 1.

Proportion of oncogenic oral HPV infections that are HPV16 versus other non-HPV16 oncogenic types among OPSCC cancer patients (PROVE study) and the general US populations ages 18–69 (NHANES) Databases. Non-HPV16 oncogenic types included 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82.